Tweets
- Tweets, huidige pagina.
- Tweets en antwoorden
- Media
Je hebt @CaribouBio geblokkeerd
Weet je zeker dat je deze Tweets wilt bekijken? @CaribouBio wordt niet gedeblokkeerd door Tweets te bekijken.
-
Thrilled to announce that the first patient has been dosed in our phase 1 clinical trial to evaluate a differentiated
#CRISPR-edited allogeneic anti-CD19 CAR-T cell therapy for patients with relapsed or refractory B cell non-Hodgkin lymphoma. Learn more: http://bwnews.pr/3e8ubSB pic.twitter.com/ONeYOz98gy
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Delighted to welcome Scott Braunstein, M.D. as the newest member of our board of directors. Bringing over 20 years of industry experience, Dr. Braunstein will be invaluable as we advance our chRDNA-edited allogeneic cell therapies. Learn more: https://bit.ly/2UigitQ pic.twitter.com/O1jc5EA5tE
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Congratulations to our President and CEO, Rachel Haurwitz, on being named to the inaugural class of @Bloomberg’s New Economy Catalysts amongst innovators focused on accelerating solutions. Learn about the#BloombergCatalysts & upcoming live event: https://bit.ly/3v8RW2H pic.twitter.com/9QZucMHXjl
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Our CEO, Rachel Haurwitz, participated in last week’s
@RNASociety entrepreneurship panel to discuss challenges & opportunities in starting a biotech company. She was joined by other leaders in the field from@variantyx,@storm_tx,@Ribometrix, MiRXES & CircCode.#RNA2021pic.twitter.com/apTlCzVuVl
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Thrilled to welcome Drs. Katy Rezvani & Christopher Sturgeon as members of our Scientific Advisory Board. Drs. Rezvani & Sturgeon will bring invaluable experience and insights as we develop genome-edited iPSC-derived NK cell therapies: Learn more: https://bit.ly/3fhf09e pic.twitter.com/uLs6AzVvsg
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
We’re excited to share Caribou’s new website! Check it out here: https://www.cariboubio.com/ pic.twitter.com/INdormpkcE
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Delighted to welcome Andrew Guggenhime as the newest member of our board of directors. With 20+ years of industry experience, his insights & expertise will help guide Caribou's evolution and strategy. Learn more: https://bit.ly/33eaYJg pic.twitter.com/vzVjfaI6Uy
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Pleased to share that our CEO, Rachel Haurwitz, is once again featured on the
@medicine_maker annual “Power List,” which honors inspirational professionals involved in drug discovery and development of advanced medicines.https://bit.ly/3n1IjjXBedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
We’re excited to share that our CEO, Rachel Haurwitz, is featured in the latest edition of the
@Biotech2050Pod podcast. She talks about her academic background, designing a new generation of#CRISPR and the founding of Caribou! Listen to the podcast here: https://bit.ly/2RtFT1I https://twitter.com/Biotech2050Pod/status/1382730604756762624 …
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Thank you
@biospace for the wonderful piece on our CEO Rachel Haurwitz, her journey in founding Caribou and the promise of our#CRISPR technology.https://bit.ly/3w5SRCuBedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
We’re delighted to announce the completion of a $115M Series C financing to advance our next-generation
#CRISPR technologies and allogenic cell therapies for#oncology. http://bit.ly/307B5QL pic.twitter.com/renQl2emTF
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
We are thrilled to announce a collaboration & multi-year license agreement for CAR-T cell products with
@abbvie allowing for the potential to develop next-generation “off-the-shelf” cellular therapies to benefit a broader patient population. Read More: http://bit.ly/3cZYU4o pic.twitter.com/JutZGDR0kp
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Delighted to welcome Jason O’Byrne as our Chief Financial Officer. Jason's deep experience in high-growth biotech environments and expertise in the genetic medicines space make him an ideal addition to our executive leadership team. Read more: http://bit.ly/3rHW9ZT pic.twitter.com/HuxC4UK8JN
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Excited to announce an exclusive license agreement with
@sloan_kettering giving Caribou rights to fully human anti-CD371 scFvs for allogeneic#celltherapies. This gives Caribou the opportunity to develop new therapies w/ significant impact for AML or MDS. https://bit.ly/3nB4lck pic.twitter.com/u6N9kiCcPu
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Unbelievably proud of our co-founder, Jennifer Doudna, and colleague,
@e__charpentier, for winning the@NobelPrize in#Chemistry for their cutting-edge development of the CRISPR-Cas9#geneticediting method. Read more about the exciting news here: https://bit.ly/3lmZhHdBedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Thrilled to announce that the
@FDA has cleared Caribou’s first IND for a CRISPR#genome-edited off-the-shelf allogeneic anti-CD19 CAR-T#celltherapy candidate for patients with relapsed/refractory B cell non-Hodgkin#lymphoma. Read more here: https://bit.ly/2F0cbvrBedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Learn about innovation & strategic thinking happening outside of the lab from our chief legal officer, Barbara McClung, who discussed all things
#biotech,#IP & negotiations on@BIOConvention’s#BIODigital panels. Register & stream Barbara’s panels: https://bit.ly/3dOwW9lBedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Excited for this year’s
@Bioconvention conference! Register for#BIODigital and stream the True North panel to hear insights and lessons learned in pursuing big ideas from our president & CEO, Rachel Haurwitz. https://bit.ly/3h5gyU0 pic.twitter.com/rgndgh1pIv
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Thrilled to welcome Cherry Thomas, MD, as our SVP of Clinical Development. Dr. Thomas offers a wealth of expertise in
#clinicaldevelopment &#immunooncology which will be integral in leading the initiation of our first clinical trial this year. https://bit.ly/3dxL0Uc pic.twitter.com/6x77dVpbRo
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken -
Would you like to be part of our exciting
#CRISPR team? Caribou is growing and we need diverse, dedicated, and driven folks who can help us achieve our#celltherapy mission. Check out our job openings and we can’t wait to hear from you. https://bit.ly/2T6aGQyBedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken
Het laden lijkt wat langer te duren.
Twitter is mogelijk overbelast of ondervindt een tijdelijke onderbreking. Probeer het opnieuw of bekijk de Twitter-status voor meer informatie.